Home
GKOS
GKOS News

Latest Glaukos Corporation (GKOS) News on December 18, 2024

MT Newswires

24 minutes ago

Truist Securities Adjusts Price Target on Glaukos to $185 From $152, Keeps Buy Rating

Glaukos Announces Participation in the J.P. Morgan Healthcare Conference

Business Wire

a day ago

Glaukos Announces Participation in the J.P. Morgan Healthcare Conference

The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen

Zacks

6 days ago

The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen

Here's Why You Should Add Glaukos Stock to Your Portfolio Now

Zacks

7 days ago

Here's Why You Should Add Glaukos Stock to Your Portfolio Now

5 Medical Device Stocks That Survived the 2024 Market Volatility

Zacks

7 days ago

5 Medical Device Stocks That Survived the 2024 Market Volatility

MT Newswires

7 days ago

Citigroup Upgrades Glaukos to Buy From Neutral, Raises Price Target to $162 From $132

Argus Research

8 days ago

GKOS: What does Argus have to say about GKOS?

Glaukos initiated with a Buy at UBS

TipRanks

11 days ago

Glaukos initiated with a Buy at UBS

MT Newswires

12 days ago

UBS Initiates Glaukos at Buy With $182 Price Target

Argus Research

15 days ago

GKOS: Lowering target price to $120.00

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos

Benzinga

16 days ago

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos

MT Newswires

16 days ago

Morgan Stanley Downgrades Glaukos Corp to Underweight

Argus Research

22 days ago

GKOS: Lowering target price to $121.00

Glaukos Stock Soars 77.9% Year to Date: What's Behind the Rally?

Zacks

a month ago

Glaukos Stock Soars 77.9% Year to Date: What's Behind the Rally?

Argus Research

a month ago

GKOS: Raising target price to $121.00

Glaukos Announces Participation in Upcoming Investor Conferences

Business Wire

a month ago

Glaukos Announces Participation in Upcoming Investor Conferences

Glaukos Corporation (NYSE:GKOS) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Simply Wall St.

a month ago

Glaukos Corporation (NYSE:GKOS) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Glaukos price target raised to $145 from $135 at Wells Fargo

TipRanks

a month ago

Glaukos price target raised to $145 from $135 at Wells Fargo

Glaukos Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a month ago

Glaukos Third Quarter 2024 Earnings: Beats Expectations

Argus Research

a month ago

GKOS: Lowering target price to $115.00

Glaukos (GKOS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

a month ago

Glaukos (GKOS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Thomson Reuters StreetEvents

a month ago

Q3 2024 Glaukos Corp Earnings Call

GKOS Stock Declines Despite Q3 Earnings & Revenues Beat Estimates

Zacks

a month ago

GKOS Stock Declines Despite Q3 Earnings & Revenues Beat Estimates

Glaukos Corp (GKOS) Q3 2024 Earnings Call Highlights: Record Sales and Raised Guidance Amid ...

GuruFocus.com

a month ago

Glaukos Corp (GKOS) Q3 2024 Earnings Call Highlights: Record Sales and Raised Guidance Amid ...

Glaukos (GKOS) Reports Q3 Loss, Tops Revenue Estimates

Zacks

a month ago

Glaukos (GKOS) Reports Q3 Loss, Tops Revenue Estimates

MT Newswires

a month ago

Glaukos Q3 Non-GAAP Loss Narrows, Sales Increase; 2024 Sales Guidance Raised

Associated Press Finance

a month ago

Glaukos: Q3 Earnings Snapshot

Glaukos Announces Third Quarter 2024 Financial Results

Business Wire

a month ago

Glaukos Announces Third Quarter 2024 Financial Results

Earnings To Watch: Glaukos Corp (GKOS) Reports Q3 2024 Result

GuruFocus.com

2 months ago

Earnings To Watch: Glaukos Corp (GKOS) Reports Q3 2024 Result

Masimo (MASI) Reports Next Week: Wall Street Expects Earnings Growth

Zacks

2 months ago

Masimo (MASI) Reports Next Week: Wall Street Expects Earnings Growth

Glaukos (GKOS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

2 months ago

Glaukos (GKOS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

GKOS Stock Rises on Positive Phase 3 Confirmatory Trial for Epioxa

Zacks

2 months ago

GKOS Stock Rises on Positive Phase 3 Confirmatory Trial for Epioxa

Glaukos eyes FDA approval for ocular therapy after Phase III win

Pharmaceutical Technology

2 months ago

Glaukos eyes FDA approval for ocular therapy after Phase III win

MT Newswires

2 months ago

Glaukos Reports Positive Results From Potential Eye Disease Treatment Study

Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa™, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety

Business Wire

2 months ago

Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa™, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety

Glaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual Meeting

Business Wire

2 months ago

Glaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual Meeting

MT Newswires

2 months ago

Truist Raises Price Target on Glaukos to $152 From $145, Maintains Buy Rating

Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4

Business Wire

2 months ago

Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4

Argus Research

2 months ago

GKOS: Raising target price to $112.00

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

Zacks

2 months ago

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

Glaukos Stock Soars 59.2% Year to Date: What's Behind the Rally?

Zacks

3 months ago

Glaukos Stock Soars 59.2% Year to Date: What's Behind the Rally?

Glaukos Stocks Rides on Strong Product Demand Amid Competition

Zacks

3 months ago

Glaukos Stocks Rides on Strong Product Demand Amid Competition

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

Zacks

3 months ago

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

Here’s Why Glaukos (GKOS) Appreciated in Q2

Insider Monkey

3 months ago

Here’s Why Glaukos (GKOS) Appreciated in Q2

Better Than Expected Earnings Results Boosted Glaukos Corp (GKOS) in Q2

Insider Monkey

3 months ago

Better Than Expected Earnings Results Boosted Glaukos Corp (GKOS) in Q2

Argus Research

4 months ago

GKOS: Raising target price to $111.00

MT Newswires

4 months ago

Needham Raises Price Target on Glaukos to $149 From $137, Maintains Buy Rating

MT Newswires

4 months ago

Glaukos Insider Sold Shares Worth $646,791, According to a Recent SEC Filing

Glaukos (GKOS) Gains 63.5% YTD: What's Driving the Stock?

Zacks

4 months ago

Glaukos (GKOS) Gains 63.5% YTD: What's Driving the Stock?

Argus Research

4 months ago

GKOS: What does Argus have to say about GKOS?

Glaukos Announces Participation in Upcoming Investor Conferences

Business Wire

4 months ago

Glaukos Announces Participation in Upcoming Investor Conferences

Glaukos Corporation (NYSE:GKOS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$133

Simply Wall St.

4 months ago

Glaukos Corporation (NYSE:GKOS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$133

Glaukos (GKOS) Reports Q2 Earnings: What Key Metrics Have to Say

Zacks

5 months ago

Glaukos (GKOS) Reports Q2 Earnings: What Key Metrics Have to Say

Should You Be Bullish on Glaukos Corporation (GKOS)?

Insider Monkey

5 months ago

Should You Be Bullish on Glaukos Corporation (GKOS)?

Glaukos Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

5 months ago

Glaukos Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Thomson Reuters StreetEvents

5 months ago

Q2 2024 Glaukos Corp Earnings Call

MT Newswires

5 months ago

Truist Adjusts Glaukos' Price Target to $145 From $141, Keeps Buy Rating

MT Newswires

5 months ago

Needham Adjusts Glaukos' Price Target to $137 From $131, Keeps Buy Rating

Glaukos (GKOS) Q2 Earnings In Line, Glaucoma Drives Sales

Zacks

5 months ago

Glaukos (GKOS) Q2 Earnings In Line, Glaucoma Drives Sales

MT Newswires

5 months ago

Glaukos Narrows Q2 Non-GAAP Loss as Net Sales Increase

Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates

Zacks

5 months ago

Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates

Associated Press Finance

5 months ago

Glaukos: Q2 Earnings Snapshot

Glaukos Announces Second Quarter 2024 Financial Results

Business Wire

5 months ago

Glaukos Announces Second Quarter 2024 Financial Results

Will These 4 MedTech Stocks Beat Forecasts This Earnings Season?

Zacks

5 months ago

Will These 4 MedTech Stocks Beat Forecasts This Earnings Season?

A Look At The Fair Value Of Glaukos Corporation (NYSE:GKOS)

Simply Wall St.

5 months ago

A Look At The Fair Value Of Glaukos Corporation (NYSE:GKOS)

Earnings Preview: Teleflex (TFX) Q2 Earnings Expected to Decline

Zacks

5 months ago

Earnings Preview: Teleflex (TFX) Q2 Earnings Expected to Decline

Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

5 months ago

Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Argus Research

5 months ago

GKOS: What does Argus have to say about GKOS?

Glaukos (GKOS) Gains 51.9% YTD: What's Driving the Stock?

Zacks

5 months ago

Glaukos (GKOS) Gains 51.9% YTD: What's Driving the Stock?

Argus Research

5 months ago

GKOS: Raising target price to $104.00

Is a Beat Likely for Edwards Lifesciences (EW) in Q2 Earnings?

Zacks

5 months ago

Is a Beat Likely for Edwards Lifesciences (EW) in Q2 Earnings?

MT Newswires

5 months ago

Morgan Stanley Raises Price Target on Glaukos to $120 From $100, Keeps Equalweight Rating

Strength Seen in CVRx (CVRX): Can Its 19.0% Jump Turn into More Strength?

Zacks

5 months ago

Strength Seen in CVRx (CVRX): Can Its 19.0% Jump Turn into More Strength?

Baxter (BAX) Shares Rise 2.4% in July: Will It Go Higher?

Zacks

5 months ago

Baxter (BAX) Shares Rise 2.4% in July: Will It Go Higher?

Business Wire

5 months ago

Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31

Argus Research

5 months ago

GKOS: Raising target price to $102.00

Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now

Zacks

5 months ago

Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now

Here's Why You Should Retain Glaukos (GKOS) Stock for Now

Zacks

6 months ago

Here's Why You Should Retain Glaukos (GKOS) Stock for Now

Glaukos (GKOS) Reaches 52-Week High: What's Driving the Stock?

Zacks

6 months ago

Glaukos (GKOS) Reaches 52-Week High: What's Driving the Stock?

Glaukos (GKOS) Stock Jumps 3.7%: Will It Continue to Soar?

Zacks

6 months ago

Glaukos (GKOS) Stock Jumps 3.7%: Will It Continue to Soar?

MT Newswires

6 months ago

Glaukos to Exchange $230 Million of Convertible Senior Notes for Common Stock

Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock

Business Wire

6 months ago

Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

6 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

6 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

6 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

6 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

6 months ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow

AFP

6 months ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

Investor's Business Daily

6 months ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

The Wall Street Journal

6 months ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

Why Is Waters (WAT) Down 5.1% Since Last Earnings Report?

Zacks

6 months ago

Why Is Waters (WAT) Down 5.1% Since Last Earnings Report?

Glaukos (GKOS) Gains 40.4% YTD: What's Driving the Rally?

Zacks

6 months ago

Glaukos (GKOS) Gains 40.4% YTD: What's Driving the Rally?

MT Newswires

6 months ago

Stifel Raises Price Target on Glaukos to $130 From $110, Maintains Buy Rating

Glaukos (NYSE:GKOS) rises 5.0% this week, taking one-year gains to 83%

Simply Wall St.

6 months ago

Glaukos (NYSE:GKOS) rises 5.0% this week, taking one-year gains to 83%

Here's Why You Should Retain Glaukos (GKOS) Stock for Now

Zacks

6 months ago

Here's Why You Should Retain Glaukos (GKOS) Stock for Now

Glaukos Announces Participation in Upcoming Investor Conferences

Business Wire

7 months ago

Glaukos Announces Participation in Upcoming Investor Conferences

MT Newswires

7 months ago

Glaukos Insider Sold Shares Worth $264,791, According to a Recent SEC Filing

Glaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?

Zacks

7 months ago

Glaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?

Earnings Update: Here's Why Analysts Just Lifted Their Glaukos Corporation (NYSE:GKOS) Price Target To US$113

Simply Wall St.

7 months ago

Earnings Update: Here's Why Analysts Just Lifted Their Glaukos Corporation (NYSE:GKOS) Price Target To US$113

MT Newswires

8 months ago

Needham Adjusts Price Target on Glaukos to $113 From $108, Maintains Buy Rating

Share on Social Networks: